$68.7 M

ALIM Mkt cap, 14-Dec-2018

$11.1 M

Alimera Sciences Revenue Q3, 2018
Alimera Sciences Net income (Q3, 2018)-3.4 M
Alimera Sciences EBIT (Q3, 2018)-2.2 M
Alimera Sciences Cash, 31-Dec-201724.1 M
Alimera Sciences EV79 M

Alimera Sciences Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

1.9m8.4m22.4m34.3m35.9m

Revenue growth, %

350%166%53%

Cost of goods sold

1.9m

Gross profit

9.0k

Gross profit Margin, %

0%

Sales and marketing expense

16.4m28.1m29.4m23.2m

R&D expense

8.4m

General and administrative expense

9.6m14.2m15.3m13.0m

Operating expense total

34.4m(39.0m)(27.8m)(16.5m)

Depreciation and amortization

2.6m2.8m2.7m

EBIT

(46.2m)(32.9m)(39.0m)(27.8m)(16.5m)

EBIT margin, %

(2469%)(391%)(174%)(81%)(46%)

Net Income

(46.2m)(35.9m)(30.6m)(33.2m)(22.0m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

758.0k2.1m2.2m2.4m3.9m5.8m6.9m5.8m9.6m8.3m6.6m10.4m9.8m9.8m10.9m11.1m

Cost of goods sold

57.0k564.0k376.0k

Gross profit

701.0k1.5m1.8m

Gross profit Margin, %

92%73%83%

Sales and marketing expense

4.5m3.4m3.1m3.7m7.1m6.9m6.9m7.1m7.5m7.5m5.5m5.1m6.0m6.0m5.9m5.5m

R&D expense

1.8m2.6m1.8m3.9m3.3m

General and administrative expense

2.1m2.9m2.8m3.0m3.6m3.8m3.0m3.4m4.0m3.6m3.3m3.0m3.3m3.9m3.2m3.4m

Operating expense total

8.4m9.0m7.8m10.6m14.1m(9.8m)(8.4m)(8.8m)(6.4m)(7.2m)(5.5m)(1.4m)(3.8m)9.8m(2.8m)(2.2m)

Depreciation and amortization

82.0k639.0k653.0k689.0k696.0k697.0k666.0k667.0k679.0k649.0k650.0k642.0k

EBIT

(11.0m)(9.8m)(8.4m)(8.8m)(6.4m)(7.2m)(5.5m)(1.4m)(3.8m)(2.8m)(2.2m)

EBIT margin, %

(279%)(170%)(122%)(152%)(67%)(87%)(83%)(13%)(39%)(25%)(20%)

Net Income

(1.1m)(20.8m)1.1m(7.0m)(9.8m)(18.4m)(19.9m)(11.1m)(18.0m)(27.2m)(6.7m)(2.8m)(5.3m)(7.7m)(4.0m)(3.4m)

Alimera Sciences Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

12.6m76.7m31.1m31.0m24.1m

Accounts Receivable

500.0k850.0k9.8m13.8m11.4m

Inventories

1.8m3.2m1.6m446.0k1.5m

Current Assets

18.6m83.3m45.2m47.4m39.3m

PP&E

1.4m

Total Assets

19.6m109.4m70.5m70.2m59.9m

Accounts Payable

1.7m5.0m4.0m5.0m5.9m

Short-term debt

1.7m31.8m34.4m

Current Liabilities

4.9m10.5m39.9m9.1m9.7m

Long-term debt

Total Debt

1.7m31.8m34.4m

Additional Paid-in Capital

240.1m292.9m299.4m330.8m341.6m

Retained Earnings

(277.3m)(313.3m)(343.9m)(377.1m)(399.1m)

Total Equity

26.3m25.6m14.9m

Debt to Equity Ratio

1.2 x

Debt to Assets Ratio

0.5 x

Financial Leverage

2.7 x2.7 x4 x

Alimera Sciences Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(46.2m)(35.9m)(30.6m)(33.2m)(22.0m)

Depreciation and Amortization

138.0k659.0k2.6m2.8m2.7m

Accounts Receivable

(483.0k)(444.0k)(8.9m)(4.1m)2.6m

Inventories

(1.4m)206.0k(386.0k)1.0m(1.1m)

Accounts Payable

(259.0k)3.0m(487.0k)1.1m644.0k

Cash From Operating Activities

(37.8m)(24.3m)(45.4m)(25.1m)(12.9m)

Purchases of PP&E

(973.0k)(842.0k)(451.0k)(186.0k)(238.0k)

Cash From Investing Activities

(973.0k)(25.8m)(451.0k)(186.0k)(238.0k)

Cash From Financing Activities

1.7m114.7m625.0k25.4m5.7m

Interest Paid

607.0k1.2m4.2m4.0m4.1m

Income Taxes Paid

263.0k193.0k74.0k
Report incorrect company information

Alimera Sciences Employee Rating

4.46 votes
Culture & Values
4.5
Work/Life Balance
3.8
Senior Management
4.5
Salary & Benefits
4.2
Career Opportunities
4.3
Source